Dr. Kavanagh has a national reputation in systems approaches to improve the care of children and adults with sickle cell disease (SCD). The Quality Lead for the Department of Pediatrics, and attending physician in the BMC Pediatric ED, she and colleagues defined and refined treatment standards for children with sickle cell disease, relevant to the Boston-area patient population but also globally. Her federal grants include a K23 from the National Heart, Lung and Blood Institute. She led the Health Resources and Services Administration’s (HRSA’s) Sickle Cell Disease Newborn Screening Program at BMC. Nationally she Co-Founded and Chaired the Taskforce for Emergency Department Sickle Cell Care Collaborative and serves on the Oversight Steering Committee of HRSA’s Sickle Cell Disease Treatment Demonstration Program, its Data and Measurement Workgroup, the Steering Committee for the American Society of Hematology’s Sickle Cell Disease Coalition, and on the national Sickle Cell Disease Council for Change.
- Active Staff Privileges, Pediatrics, Boston Medical Center
- Boston University, MD
- Boston University, BS
- Boston University, BA
- Published on 5/17/2018
Akinsola B, Hagbom R, Zmitrovich A, Kavanagh PL, Ashkouti A, Simon HK, Fleming A, Jain S, Dampier C, Morris CR. Impact of Intranasal Fentanyl in Nurse Initiated Protocols for Sickle Cell Vaso-occlusive Pain Episodes in a Pediatric Emergency Department. Am J Hematol. 2018 May 17. PMID: 29770479.
- Published on 4/29/2017
Lewen MO, Kavanagh PL, Sobota AE. A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia. Am J Hematol. 2017 06; 92(6):E121-E122. PMID: 28335074.
- Published on 9/21/2015
Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department. Pediatrics. 2015 Oct; 136(4):e1016-25. PMID: 26391933.
- Published on 12/24/2014
Sobota AE, Kavanagh PL, Adams WG, McClure E, Farrell D, Sprinz PG. Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic. Pediatr Blood Cancer. 2015 Apr; 62(4):654-7. PMID: 25545967.
- Published on 11/17/2014
Walsh KE, Cutrona SL, Kavanagh PL, Crosby LE, Malone C, Lobner K, Bundy DG. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics. 2014 Dec; 134(6):1175-83. PMID: 25404717.
- Published on 4/16/2014
Taylor C, Kavanagh P, Zuckerman B. Sickle cell trait--neglected opportunities in the era of genomic medicine. JAMA. 2014 Apr 16; 311(15):1495-6. PMID: 24604073.
- Published on 6/13/2013
Parker MG, Barrero-Castillero A, Corwin BK, Kavanagh PL, Belfort MB, Wang CJ. Pasteurized human donor milk use among US level 3 neonatal intensive care units. J Hum Lact. 2013 Aug; 29(3):381-9. PMID: 23764482.
- Published on 3/4/2013
Chawla A, Sprinz PG, Welch J, Heeney M, Usmani N, Pashankar F, Kavanagh P. Weight status of children with sickle cell disease. Pediatrics. 2013 Apr; 131(4):e1168-73. PMID: 23460681.
- Published on 7/1/2012
Kenyon CC, Kavanagh PL, Fiechtner LG, Textor TE, Wang CJ. Setting the agenda for quality improvement in pediatric sickle cell disease. J Natl Med Assoc. 2012 Jul-Aug; 104(7-8):337-41. PMID: 23092048.
- Published on 11/28/2011
Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ. Management of children with sickle cell disease: a comprehensive review of the literature. Pediatrics. 2011 Dec; 128(6):e1552-74. PMID: 22123880.
View 9 more publications: View full profile at BUMC